Quest (DGX) Q1 2026 Earnings Transcript [Globe and Mail, The (Toronto, Canada)]
Quest Diagnostics Incorporated (DGX)
Last quest diagnostics incorporated earnings: 4/22 06:45 am
Check Earnings Report
US:NYSE Investor Relations:
ir.questdiagnostics.com
Company Research
Source: Globe and Mail, The
Chairman, Chief Executive Officer, and President — James E. Davis Executive Vice President and Chief Financial Officer — Sam Samad TAKEAWAYS Revenue -- $2.9 billion, up 9.2% primarily due to organic growth from increased demand and expanded collaborations. Organic Revenue Growth -- 9% with broad-based contributions across physician, hospital, and consumer channels. Total Volume -- Increased 10.9%, driven by strong organic demand and significant contributions from Fresenius Medical Care and Corewell Health relationships. Organic Volume Growth (Excluding Fresenius/Corewell) -- 3.8%, indicating underlying channel strength beyond partnership effects. Revenue per Requisition -- Decreased 1.3% overall, but increased approximately 2.5% when excluding Fresenius and Corewell's business mix. Operating Income -- $399 million reported (13.8% of revenue) and $447 million adjusted (15.4% of revenue), with improved margins driven by productivity and volume. Adjusted Diluted EPS --
Show less
Read more
Impact Snapshot
Event Time:
DGX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
DGX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
DGX alerts
High impacting Quest Diagnostics Incorporated news events
Weekly update
A roundup of the hottest topics
DGX
News
- Quest Diagnostics (DGX) was given a new $225.00 price target by Evercore Inc.MarketBeat
- Quest Diagnostics (DGX) had its "buy" rating reaffirmed by Jefferies Financial Group Inc..MarketBeat
- Quest Diagnostics Incorporated (DGX) Q1 2026 Earnings Call Transcript [Seeking Alpha]Seeking Alpha
- Quest Diagnostics Reports First Quarter 2026 Financial Results; Raises Revenue and EPS Guidance for Full Year 2026 [TheStreet.com]TheStreet.com
- Quest Diagnostics Reports First Quarter 2026 Financial Results; Raises Revenue and EPS Guidance for Full Year 2026PR Newswire
DGX
Earnings
- 4/21/26 - Beat
DGX
Sec Filings
- 4/21/26 - Form 8-K
- 4/6/26 - Form DEFA14A
- 4/6/26 - Form DEF
- DGX's page on the SEC website